Steven Oliveira
Presidente en Oliveira Capital LLC .
Fortuna: 343 569 $ al 31/05/2024
Perfil
Steven M.
Oliveira is the founder of SIGA Technologies, Inc. founded in 1995.
He is also the founder of Assertio Therapeutics, Inc. Mr. Oliveira's current job is President at Oliveira Capital LLC since 2002.
Mr. Oliveira's former jobs include Director at Repros Therapeutics, Inc., Director at Ideanomics, Inc. from 2010 to 2011, Independent Director at Pulte Acquisition Corp., Chief Investment Officer at Chardan SPAC Asset Management LLC from 2008 to 2013, and Managing Partner at CSO Ventures.
Mr. Oliveira received his undergraduate degree from Manhattan College in 1989.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BENITEC BIOPHARMA INC
0.48% | 22/04/2024 | 44 911 ( 0.48% ) | 343 569 $ | 31/05/2024 |
Cargos activos de Steven Oliveira
| Empresas | Cargo | Inicio |
|---|---|---|
| Oliveira Capital LLC | Presidente | 01/01/2002 |
Antiguos cargos conocidos de Steven Oliveira.
| Empresas | Cargo | Fin |
|---|---|---|
| Chardan SPAC Asset Management LLC | Director de Inversiones | 01/01/2013 |
| IDEANOMICS, INC. | Director/Miembro de la Junta | 30/03/2011 |
| REPROS THERAPEUTICS INC | Director/Miembro de la Junta | - |
| SIGA TECHNOLOGIES, INC. | Fundador | - |
| CSO Ventures | Corporate Officer/Principal | - |
Formación de Steven Oliveira.
| Manhattan College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| IDEANOMICS, INC. | Consumer Durables |
| SIGA TECHNOLOGIES, INC. | Health Technology |
| Empresas privadas | 6 |
|---|---|
Pulte Acquisition Corp.
 Pulte Acquisition Corp. MiscellaneousMiscellaneous Pulte Acquisition Corp. operates as a blank check company. The company is headquartered in Chicago, IL. | Miscellaneous |
| Oliveira Capital LLC | |
| Chardan SPAC Asset Management LLC | |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
| CSO Ventures | |
Repros Therapeutics, Inc.
 Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
- Bolsa de valores
- Insiders
- Steven Oliveira
